Loading
HT
Horizon Technology Finance Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by ALLISON THOMAS J., was filed 10 Jun 2026.
Horizon Technology Finance Corp: what insiders have been doing
Every trade that managers of Horizon Technology Finance Corp disclose to SEC (Form 4) is tracked on this page. The company sits in the Finance & Banking sector. 4 insiders have disclosed 7 filings since 22 October 2025.
Every open-market trade in the period is a purchase: 3 purchases worth €421k, from 3 insiders, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 2 senior executives and 1 chief executive. Biggest ticket of the year: €376k, bought by Balkin Michael and made public on 10 June 2026.
Within a 30-day window, 3 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (10 June 2026) now reads 136 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4.
Across the 3,171 companies tracked on its exchange, the median is 24 filings; at 7 filings, this issuer sits below that mark. Looking back to 2016, when coverage begins, insiders filed 62 purchases and no sales. The 10-K for the year ended 31 December 2025 shows -2.7 m USD of net income and a dividend of 1.32 USD per share.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
66
Thresholds
n/a
Buy Volume
€3M
62 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJoseph J. Savage2 buys
Michael Balkin2 buys
Gerald A. Michaud1 buy
Jonathan Joseph Goodman1 buy
Thomas J. Allison1 buy
Since the insiders bought
- -11.5%Entry US$4.57 · Close 21 Oct 2026 US$4.05
- -11.5%Entry US$4.57 · Close 21 Oct 2026 US$4.05
- -11.5%Entry US$4.57 · Close 21 Oct 2026 US$4.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Horizon Technology Finance Corp Buy (bullish), based on 6 analysts. Average price target: US$5.08.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,120 of 26,284 companies
38.9
score / 100
Value59
Quality18
FCF yld20%
Earn yld-0.9%
EV/EBITDA·
ROE1.4%
Gross mgn·
Net mgn-37%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$4.11
Analyst consensus
6 analystsBuy
US$4.50Target US$5.08(+24%)US$6.00
Income statement
RevenueUS$7.2M
Net income-US$2.7M5.3% margin
Valuation
PER (trailing)14.2x
PER (forward)5.6x
P/Book0.7x
Beta0.99
Balance sheet & cash
Market capUS$280.2M
Total debtUS$473M
Free Cash FlowUS$56.6M
Debt / Equity96%
Profitability & ownership
ROE1.4%
ROA6.1%
% insiders0.3%
% institutions12.5%
Last declaration on 10 June 2026
Declarations66 total
6,000 shares@ US$4.32549.6% of flowCommon StockSEC:0001437749-26-020170:0
Canonical exit: 7 Sept 2026 (T+90)
100,000 shares@ US$4.3459.2% of flowCommon StockSEC:0001437749-26-020103:1
Canonical exit: 7 Sept 2026 (T+90)
6,000 shares@ US$4.36100.0% of flowCommon StockSEC:0000945621-26-000816:0
Canonical exit: 7 Sept 2026 (T+90)
93,527 sharesCommon StockSEC:0001437749-26-020103:0
49,926 sharesCommon StockSEC:0000945621-26-000574:0
93,527 sharesCommon StockSEC:0001437749-26-012279:0
142 sharesCommon StockSEC:0001437749-26-012280:0
20,000 shares@ US$8.5362.7% of flowCommon StockSEC:0001437749-24-037709:0
Canonical exit: 16 Mar 2025 (T+90)
8,000 shares@ US$9.314915.3% of flowCommon StockSEC:0001437749-24-036405:0
Canonical exit: 23 Feb 2025 (T+90)
4,500 shares@ US$9.207.1% of flowCommon StockSEC:0001437749-24-035325:1
Canonical exit: 12 Feb 2025 (T+90)
5,000 shares@ US$9.3520.2% of flowCommon StockSEC:0001437749-24-035325:0
Canonical exit: 11 Feb 2025 (T+90)
10,000 shares@ US$10.5837.3% of flowCommon StockSEC:0001437749-24-024617:0
Canonical exit: 3 Nov 2024 (T+90)
2,313 shares@ US$10.81100.0% of flowCommon StockSEC:0001437749-24-024620:0
Canonical exit: 3 Nov 2024 (T+90)
3,650 shares@ US$11.778.4% of flowCommon StockSEC:0001437749-24-007312:0
Canonical exit: 6 Jun 2024 (T+90)
18,250 shares@ US$11.0340.7% of flowCommon StockSEC:0001437749-22-029511:0
Canonical exit: 20 Mar 2023 (T+90)
600 shares@ US$13.031.1% of flowCommon StockSEC:0001437749-22-028839:1
Canonical exit: 9 Mar 2023 (T+90)
4,000 shares@ US$13.0323.5% of flowCommon StockSEC:0001437749-22-028839:0
Canonical exit: 9 Mar 2023 (T+90)
4,000 shares@ US$12.9010.5% of flowCommon StockSEC:0001437749-22-028617:0
Canonical exit: 6 Mar 2023 (T+90)
758 shares@ US$13.0466.9% of flowCommon StockSEC:0001437749-22-027595:0
Canonical exit: 14 Feb 2023 (T+90)
500 shares@ US$9.88100.0% of flowCommon StockSEC:0001437749-22-023280:0
Canonical exit: 28 Dec 2022 (T+90)
4,000 shares@ US$11.300.015% mcap20.4% of flowCommon StockSEC:0001415889-22-006833:0
Canonical exit: 19 Sept 2022 (T+90)
10,000 shares@ US$12.2353.7% of flowCommon StockSEC:0001415889-22-005108:0
Canonical exit: 14 Aug 2022 (T+90)
5,000 shares@ US$11.8226.1% of flowCommon StockSEC:0001415889-22-004917:0
Canonical exit: 10 Aug 2022 (T+90)
414 shares@ US$12.0033.1% of flowCommon StockSEC:0001415889-22-004829:0
Canonical exit: 8 Aug 2022 (T+90)
3,050 shares@ US$12.067.5% of flowCommon StockSEC:0001415889-22-004822:0
Canonical exit: 7 Aug 2022 (T+90)
25 of 66 declarations
About Horizon Technology Finance Corp
Horizon Technology Finance Corp. is a U.S.-listed specialty finance company trading on the NASDAQ under the ticker HRZN. The company was organized as a Delaware corporation on March 16, 2010, and operates as a non-diversified, externally managed business development company (BDC). Its operating footprint is centered in Farmington, Connecticut, with an additional presence in California, underscoring a U.S.-focused platform built to serve the domestic venture and growth financing market. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1487428/000143774926006636/R12.htm?utm_source=openai))
Horizon’s core business is providing secured loans to venture capital-backed and private equity-backed companies, as well as to publicly traded growth businesses in targeted industries. Historically, its lending focus has concentrated on technology, life sciences, healthcare, healthcare services, and sustainability-related businesses. In practical terms, Horizon is a specialized credit investor that seeks income through structured debt investments and, in some cases, equity-linked upside through warrant positions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1487428/000143774925017203/ex_818593.htm?utm_source=openai))
Read moreShow less
From a competitive standpoint, Horizon occupies a niche within the U.S. financial sector: venture lending and specialty finance. Its competitive edge comes from sector specialization, underwriting discipline in asset-backed or secured structures, and close relationships with venture capital ecosystems. That specialization differentiates it from broad-based lenders, but it also means the company is more exposed to credit risk, valuation swings in its portfolio companies, and the capital-markets cycle affecting innovation-driven businesses. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1487428/000143774925017203/ex_818593.htm?utm_source=openai))
Recent developments highlight both portfolio performance and corporate activity. In its March 2026 announcement of fourth-quarter and full-year 2025 results, the company reported a total investment portfolio of $647.2 million, net asset value of $318.5 million, or $6.98 per share, and an annualized debt-investment yield of 14.3% for the fourth quarter of 2025. Horizon also disclosed $154 million of committed backlog at year-end. In addition, the company announced in 2026 that a merger involving Monroe Capital Corporation was moving forward, with HRZN expected to remain the surviving publicly traded entity on the NASDAQ. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1512931/000143774926006801/hrzn20260303c_425.htm?utm_source=openai))
For French-speaking investors, HRZN is best viewed as a U.S. listed income-oriented specialty finance stock, tied to the financing of technology and healthcare growth companies, with a yield-driven profile that is highly sensitive to credit quality and the U.S. interest-rate environment.
